HealthcareAssociatedInfectionReports Implementation Guide CI Build

This page is part of the Healthcare Associated Infection Implementation Guide (v2.0.0: STU 2) based on FHIR R4. This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

CodeSystem: 2.16.840.1.113883.6.277

CDC - National Healthcare Safety Network (NHSN) code system

CDC - National Healthcare Safety Network (NHSN) code system - A set of patient safety and healthcare personnel safety vocabulary concepts and associated identifiers maintained as a code system by the CDC's National Healthcare Safety Network.

This code system http://hl7.org/fhir/us/hai/CodeSystem/2.16.840.1.113883.6.277 defines the following codes:

CodeDisplayDefinition
1601-4 Breast abscess or mastitis
1602-2 Myocarditis or pericarditis
1603-0 Clinical sepsis
1604-8 Deep incisional primary SSI
1605-5 Deep incisional secondary SSI
1606-3 Vertebral disc space infection
1607-1 Ear or mastoid infection (otitis externa, otitis media, otitis interna, mastoiditis)
1608-9 Eye infection, other than conjunctivitis
1609-7 Gastrointestinal tract infection (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis
1610-5 Intraabdominal infection, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere
1611-3 Intracranial infection (brain abscess, subdural or epidural infection, encephalitis)
1612-1 Joint or bursa infection
1613-9 Laboratory-confirmed bloodstream infection
1614-7 Other infections of the lower respiratory tract, other than pneumonia
1615-4 Meningitis or ventriculitis
1616-2 Oral cavity infection (mouth, tongue, or gums)
1617-0 Other infections of the male or female reproductive tract (epididymis, testes, prostate, vagina, ovaries, uterus, or other deep pelvic tissues, excluding endometritis or vaginal cuff infections)
1618-8 Other infections of the urinary tract (kidney, ureter, bladder, urethra, or tissue surrounding the retroperitoneal or perinephric space)
1619-6 Spinal abscess without meningitis
1620-4 Superficial incisional primary SSI
1621-2 Superficial incisional secondary SSI
1622-0 Upper respiratory tract infection, pharyngitis, laryngitis, epiglottitis
1623-8 Arterial or venous infection
1624-6 Vaginal cuff infection
1625-3 Symptomatic UTI (SUTI)
1626-1 PNU1
1631-1 PNU2
1632-9 PNU3
1671-7 Bronchitis, tracheitis
1672-5 Burn
1673-3 Decubitus ulcer
1674-1 Disseminated infection
1675-8 Infant pustulosis
1676-6 Newborn circumcision
1677-4 Soft tissue, muscle, lymph node, or salivary gland
2402-6 Asymptomatic Bacteremic UTI (ABUTI)
1970-3 Periprosthetic Joint Infection
1640-2 Organ/space
2343-4 VAC - Ventilator-Associated Condition
2344-2 IVAC - Infection-related Ventilator-Associated Complication
2345-0 PVAP - Possible Ventilator-Associated Pneumonia
3066-8 Neonatal Laboratory Confirmed Bloodstream Infection (NLCBI 1)
3067-6 Neonatal Laboratory Confirmed Bloodstream Infection (NLCBI 2)
3068-4 Neonatal Laboratory Confirmed Meningitis (NLCM 1)
3069-2 Neonatal Laboratory Confirmed Meningitis (NLCM 2)
2526-2 Micafungin Susc Islt
1206-2 Float
1792-1 MDRO Infection
1795-4 CDAD Infection
1796-2 Infection of the Reproduction System
1797-0 Infection of the Ear/Eyes/Nose or Throat
1798-8 Bone or Joint Infection
2340-3 Ventilator Associated Event
1901-8 Not cultured
1964-6 Allo-SCT with Grade > 3 GI GVHD
1965-3 Allo- SCT with diarrhea
1966-1 Positive culture from greater than or equal to two separate tissue or fluid samples from affected joint
1902-6 Blood culture not done or no organisms detected in blood
1929-9 >=2 positive cultures with >=10^2 col/ml of same uropathogen from nonvoided specimen
1931-5 >=2 positive urine cultures with >=10^5 col/cc with no more than 2 organisms
1923-3 >=5% BAL cells w/bacteria
1942-2 >15 colonies cultured from IV cannula tip using semiquantitative culture method
1927-3 1 positive culture with >=10^5 col/cc with no more than 2 organisms
2403-4 1 positive culture with >=103 CFU/ml and <105 CFU/ml with no more than 2 species of microorganisms
1930-7 1 positive culture with <=10^5 col/ml of a single uropathogen in patient being treated with an effective antimicrobial agent for UTI
1938-0 4-fold rise in L. pneumophila antibody titer
1935-6 4-fold rise in paired sera for pathogen
1944-8 Common skin contaminant from >2 blood cultures (see NHSN protocol for definition of skin contaminant)
1937-2 L pneumophila serogroup 1 antigens in urine
1939-8 Matching positive blood and sputum cultures w/ Candida spp
1941-4 Other positive laboratory tests
1955-4 Positive blood culture
1952-1 Positive culture
1953-9 Positive culture of pathogen
1954-7 Positive culture of skin contaminant
1948-9 Positive culture of virus or Chlamydia
1936-4 Positive culture or micro-IF of Legionella spp
1934-9 Positive detection of viral antigen or antibody
1928-1 Positive dipstick for leukocyte esterase or nitrate
1943-0 Positive Gram stain when culture is negative or not done
1950-5 Positive micro-IF test for Chlamydia
1949-7 Positive PCR for Chlamydia or Mycoplasma
1946-3 Positive pleural fluid culture
1947-1 Positive quantitative culture from LRT specimen
1924-0 Radiographic evidence of infection
1951-3 Recognized pathogen from one or more blood cultures
1957-0 Acute onset of diarrhea (liquid stools for > 12 hours)
1959-6 Apnea, tachycardia, nasal flaring with retraction of chest wall or grunting
2513-0 Bilateral infiltrates on chest x-ray
1908-3 Bradycardia or tachycardia
2516-3 Criterion not otherwise specified
2514-8 Diffuse hemorrhage
1940-6 Fungi or Pneumocytis carinii from LRT specimen
1956-2 Histopathologic exam w/ abscess formation, positive quantitative culture of lung parenchyma, or positive quantitative culture of lung parenchyma, or lung parenchyma invasion by fungal hyphae
1967-9 Incision deliberately opened or otherwise drained by physician
1920-8 Localized swelling
2515-5 Nausea/vomiting
1903-4 New onset/change in sputum
1907-5 New onset/change in sputum, increased secretions or increased suctioning
1904-2 New onset/worsening cough, dyspnea, tachypnea
1925-7 New or progressive and persistent infiltrate
1905-9 Other evidence of infection found on direct exam, during surgery, or by diagnostic tests
1906-7 Other signs and symptoms
2517-1 Pain not otherwise specified
1960-4 Pain or tenderness
1909-1 Persistent microscopic or gross blood in stools
1963-8 Physician diagnosis of this event type
1962-0 Physician institutes appropriate antimicrobial therapy
1926-5 Pneumatoceles (in <=1 y.o.)
1921-6 Rales or bronchial breath sounds
2518-9 Rash not otherwise specified
1968-7 Sinus tract
1922-4 Wheezing, rales or rhonchi
1958-8 Worsening gas exchange
2320-0 Wound (not related to vascular access) with pus or increased redness
1971-1 Acute pain, swelling, or tenderness of testes, epididymis, or prostate
1972-9 Urine not tested for WBC
2351-1 Criterion 1 - Positive culture from Endotracheal aspirate without purulent respiratory secretions
2352-5 Criterion 1 - Positive culture from Bronchoalveolar lavage without purulent respiratory secretions
2353-3 Criterion 1 - Positive culture from Lung tissue without purulent respiratory secretions
2354-1 Criterion 1 - Positive culture from Protected specimen brush without purulent respiratory secretions
2355-9 Criterion 2 - Purulent respiratory secretions plus organism(s)
2356-4 Criterion 2 - Organisms from Sputum cluture with purulent respiratory secretions
2357-2 Criterion 2 - Organisms from Endotracheal aspirate culture with purulent respiratory secretions
2358-0 Criterion 2 - Organisms from Bronchoalveolar lavage culture with purulent respiratory secretions
2359-8 Criterion 2 - Organisms from Lung tissue culture with purulent respiratory secretions
2360-1 Criterion 2 - Organisms from Protected specimen brush culture with purulent respiratory secretions
2361-0 Criterion 3 - Positive test Organism(s) identified from pleural fluid
2362-4 Criterion 3 - Positive test for Lung histopathology
2363-2 Criterion 3 - Positive Diagnostic test for Legionella species
2364-0 Criterion 3 - Positive Diagnostic test for selected viral pathogens
2346-5 Daily min FiO2 increase > 0.20 (20 points) for > 2 days
2347-3 Daily min PEEP increase > 3 cm H2O for > 2 days
2348-1 Temperature > 380 C or < 360 C
2349-9 White blood cell count >= 12,000 or <= 4,000 cells/mm3
2350-2 A new antimicrobial agent(s) is started, and is continued for >= 4 days
3070-0 Common commensal from blood specimen(s) and antibiotics for greater than or equal to 5 days
3072-6 Common commensal from cerebrospinal fluid specimen and antibiotics for greater than or equal to 5 days
3071-8 Recognized pathogen from cerebrospinal fluid specimen
2126-1 Limb amputation
2108-9 Appendix surgery
2102-2 Shunt for dialysis
2109-7 Bile duct, liver or pancreatic surgery
2110-5 Breast surgery
2114-7 Carotid endarterectomy
2119-6 Gallbladder surgery
2116-2 Colon surgery
2115-4 Cesarean section
2137-8 Spinal fusion
2129-5 Open reduction of fracture
2120-4 Gastric surgery
2106-3 Herniorrhaphy
2101-4 Total hip replacement
2107-1 Abdominal hysterectomy
2124-6 Knee prosthesis
2125-3 Laminectomy
2128-7 Neck surgery
2122-0 Kidney surgery
2130-3 Ovarian surgery
2131-1 Pacemaker surgery
2133-7 Prostate surgery
2132-9 Peripheral Vascular Bypass Surgery
2134-5 Rectal surgery
2136-0 Small bowel surgery
2138-6 Spleen surgery
2139-4 Thoracic surgery
2140-2 Thyroid and/or parathyroid surgery
2141-0 Vaginal hysterectomy
2142-8 Ventricular shunt
2118-8 Abdominal surgery
1311-0 No location change
1645-1 Hospital transer/admission
1646-9 Wrong site
1647-7 Wrong side
1648-5 Wrong patient
1649-3 Wrong implant
1657-6 Summary data reporting outpatient procedure component events at a facility
1890-3 Number of Total Facility Encounters (for outpatient location)
1340-9 No Same Day Outcome Measures (events) reported this month
1006-6 central line including umbilical catheter
1309-4 Active SSI Detection Method
1312-8 Passive SSI Detection Method
1321-9 Review of patient's medical record
1322-7 Post-discharge surgeon survey
1323-5 Post-discharge patient letter
1324-3 Post-discharge patient phone call
1325-0 Cooperative infection prevention process between facilities
1326-8 Patient/caregiver contacts facility to report
1327-6 Patient returns to outpatient facility for follow-up
1328-4 Surgeon contacts facility to report
1329-2 Report from another facility (inpatient, health department, emergency department, etc.)
1879-6 Summary data reporting catheter and ventilator use in a ICU/Other
1880-4 Summary data reporting catheter and ventilator use in a SCA
1881-2 Summary data reporting catheter and ventilator use in a NICU
1884-6 Summary data reporting Active Surveillance Testing
2316-8 Summary data reporting vascular access types for chronic hemodialysis patients
1887-9 Summary data reporting Antimicrobial Usage
2410-9 Summary data reporting antimicrobial resistance patterns at a facility
2543-7 Hemovigilance Module - Monthly Reporting Denominator